Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Biguanides
Status:
Completed
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
To examine the safety and efficacy of long-term combination therapy with alogliptin (Nesina)
and biguanides in patients with type 2 diabetes mellitus who responded inadequately to
treatment with biguanides in addition to diet therapy and exercise therapy.